In these challenging economic times, it's critical to highlight the good news. Medtronic's (Minneapolis) recent profits report and the company's subsequent $1.025 billion acquisition of two heart valve companies is welcome, optimistic news worth talking about.

Also, in our continuing coverage of stem cell policy changes, we blur the line between religion and science in asking two writers for their opposing views of this volatile issue. Read about these hot topics in tomorrow's edition of MDD Perspectives, an op-ed e-zine that provides fresh commentary and opinions on issues that you can't find anywhere else. And best of all, it's free.

If you don't already subscribe to this complimentary e-zine, go to medicaldevicedaily.com to sign up.

No Comments